Cited by 341Cancer, Hypoxia, and MetabolismGlioma Diagnosis and TreatmentMetabolomics and Mass Spectrometry Studies

Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo

Open access
Maher, Elizabeth A., Marin‐Valencia, Isaac, Bachoo, Robert M., Mashimo, Tomoyuki, Raisanen, Jack, Hatanpaa, Kimmo J., Jindal, Ashish, Jeffrey, F. Mark +7 more·2012·NMR in Biomedicine

Abstract

Glioblastomas and brain metastases demonstrate avid uptake of 2-[(18) F]fluoro-2-deoxyglucose by positron emission tomography and display perturbations of intracellular metabolite pools by (1) H MRS. These observations suggest that metabolic reprogramming contributes to brain tumor growth in vivo. The Warburg effect, excess metabolism of glucose to lactate in the presence of oxygen, is a hallmark of cancer cells in culture. 2-[(18) F]Fluoro-2-deoxyglucose-positive tumors are assumed to metabolize glucose in a similar manner, with high rates of lactate formation relative to mitochondrial glucose oxidation, but few studies have specifically examined the metabolic fates of glucose in vivo. In particular, the capacity of human brain cancers to oxidize glucose in the tricarboxylic acid cycle is unknown. Here, we studied the metabolism of human brain tumors in situ. [U-(13) C]Glucose (uniformly labeled glucose, i.e. d-glucose labeled with (13) C in all six carbons) was infused during surgical resection, and tumor samples were subsequently subjected to (13) C NMR spectroscopy. The analysis of tumor metabolites revealed lactate production, as expected. We also determined that pyruvate dehydrogenase, turnover of the tricarboxylic acid cycle, anaplerosis and de novo glutamine and glycine synthesis contributed significantly to the ultimate disposition of glucose carbon. Surprisingly, less than 50% of the acetyl-coenzyme A pool was derived from blood-borne glucose, suggesting that additional substrates contribute to tumor bioenergetics. This study illustrates a convenient approach that capitalizes on the high information content of (13) C NMR spectroscopy and enables the analysis of intermediary metabolism in diverse cancers growing in their native microenvironment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/nbm.2794

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tracing glucose-derived carbons in human patients and mouse models of glioblastoma and NSCLC reveals that in these contexts the principal source for TCA cycle intermediates is glucose, not glutamine.

    “In fact, tracing the fate of glucose-derived carbons in human patients and in mouse models of glioblastoma and non-small cell lung carcinoma (NSCLC) reveals that at least in these tumorigenic contexts, the principal source for the TCA cycle intermediates is not glutamine, but glucose (Maher et al., 2012; Marin-Valencia et al., 2012; Sellers et al., 2015).”

    From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Maher et al., 2012

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., Mathews, D., Pascual, J. M., Mickey, B. E., Malloy, C. R., & DeBerardinis, R. J.
Affiliations
  • Harold C. Simmons Comprehensive Cancer Center (US)
  • The University of Texas Southwestern Medical Center (US)
  • VA North Texas Health Care System (US)
Corresponding author
  • Maher, Elizabeth A.
  • DeBerardinis, Ralph J.
Venue
NMR in Biomedicine
Publisher
Wiley
Published
2012-03-15
Volume
25
Issue
11
Pages
1234-1244
ISSN
  • 0952-3480 (ISSN-L)
  • 1099-1492
OpenAlex
W2114805483
Cited by
341
References
49
Citations by year
2026: 16 · 2025: 22 · 2024: 21 · 2023: 19 · 2022: 28 · 2021: 41 · 2020: 28 · 2019: 30 · 2018: 22 · 2017: 18 · 2016: 34 · 2015: 33 · 2014: 14 · 2013: 11 · 2012: 4
FWCI
6.54
Type
journal article
Language
en
Open access
Locations
  • NMR in Biomedicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health
  • National Cancer Institute (R01CA154843, R01CA157996)
  • National Institute of Neurological Disorders and Stroke (RC1NS0760675, RC1NS070675)
  • National Center for Research Resources (P41RR002584, RR‐02584)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
brain tumors, glioblastoma, brain metastases, glucose metabolism, Warburg effect, lactic acid production, TCA cycle, pyruvate dehydrogenase, anaplerosis, acetyl-CoA, tumor bioenergetics, metabolic reprogramming
MeSH terms
Acetyl Coenzyme A, Blood Glucose, Brain Neoplasms, Breast Neoplasms, Carbon Isotopes, Carcinoma, Non-Small-Cell Lung, Citric Acid Cycle, Female, Glioblastoma, Glucose, Glycine, Glycolysis, Humans, Oxidation-Reduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review